Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +524.0% | +304.0% | 3 / 3 | +36.8% | +0.93 pp | +4.91 pp | +116.1% | 17.63 | 1.60 | 658 | +36,8% | 24,4 | +524,0% | 1.60 | 1.03 | +55,6% |
| Pts | 12 | 12 | 12 | 12 | 8 | 12 | 12 | -4 | 4 | |||||||
Valuation annotation:Price: 6.000 (close price on 2026-10-19)EPS (TTM): 3.744
Financial charts
1.Revenue & growth
VND bn658Q2/26
1.Revenue & growth
VND bn658Q2/26
2.Profit & growth
VND bn23,9Q2/26
3.Profit mix (Penman)
VND bn50,2Q2/26
4.Margins & cost structure
%4.3%Q2/26
5.Returns & cash cycle
% · days5.8%Q2/26
6.Earnings quality & cash
VND bn-140Q2/26
7.Asset structure
VND bn1.063Q2/26
8.Funding & debt health
VND bn · times1.063Q2/26
9.Revenue backlog
VND bn15,2Q2/26
10.Valuation
times · %1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.765Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
11.3%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26